14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
NXE vs UROY: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Uranium Royalty Corp. (UROY) is the stronger overall head-to-head candidate over NexGen Energy Ltd. (NXE) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NXE carries a Unified Composite Score of 54.2/100 (HOLD) at $7.43 (N/M Forward P/E, 0.0% operating margin), whereas UROY carries 44.9/100 (HOLD) at $2.65 (69.5x Forward P/E, 30.2% operating margin).
Composite vs. Pillar Nuance: While NXE currently prints a higher short-term Unified Composite Score (54.2/100 HOLD vs. UROY 44.9/100 HOLD), UROY captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (30.2% vs. 0.0% operating margin) and revenue trajectory (+112.9% vs. +0.0% YoY).
Technical & Structure Timing Caution: NXE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 36.0); meanwhile UROY is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 28.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NXE vs UROY. Trailing 12-month operating profitability (NXE 0.0% vs UROY 30.2%) and valuation multiples (NXE N/M vs UROY 69.5x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Uranium value chain with $5.3B market capitalization and 0.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
UROY Moat ProfileHigh-Margin Pricing Power Moat
Uranium Operator
Competes within the Uranium value chain with $1.1B market capitalization and 30.2% operating margin.
OpEx & R&D Reinvestment2.9% of Rev ($16M)
90D Engineering Disclosures0 Published
Investor FAQ NXE vs UROY Key Questions & Quantitative Answers
As of Nov 16, 2026, Uranium Royalty Corp. (UROY) is the stronger overall head-to-head candidate over NexGen Energy Ltd. (NXE) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NXE carries a Unified Composite Score of 54.2/100 (HOLD) at $7.43 (N/M Forward P/E, 0.0% operating margin), whereas UROY carries 44.9/100 (HOLD) at $2.65 (69.5x Forward P/E, 30.2% operating margin). Composite vs. Pillar Nuance: While NXE currently prints a higher short-term Unified Composite Score (54.2/100 HOLD vs. UROY 44.9/100 HOLD), UROY captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (30.2% vs. 0.0% operating margin) and revenue trajectory (+112.9% vs. +0.0% YoY). Technical & Structure Timing Caution: NXE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 36.0); meanwhile UROY is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 28.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
UROY leads the Growth & Scale pillar: NXE posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with UROY at +112.9% YoY revenue growth and N/A YoY earnings growth on $560M TTM revenue (33.1% gross margin, 30.2% operating margin). On trailing 12-month operating scale, NXE generates N/A in USD-normalized revenue versus $560M for UROY. In operating R&D and SG&A reinvestment, NXE deploys N/A (0 90-day corporate R&D disclosures) versus 2.9% of Rev ($16M) (0 disclosures) for UROY.
UROY screens cheaper on headline valuation multiples. NXE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin), whereas UROY trades at 69.5x Forward P/E, 7.4x Trailing P/E, N/M PEG, and 4.4x EV/Revenue (97.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NXE (-10.3% ROE) versus UROY (8.5% ROE) capital efficiency.
In options market volatility and institutional positioning, NXE carries 52.6% implied volatility (16th %ile, Compressed (<25th %ile)), a 0.70x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.04β · 55% Vol realized risk). By comparison, UROY carries 67.2% implied volatility (31st %ile, Balanced (25th–60th %ile)), a 0.71x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.93β · 66% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.